Cuprina Holdings (Cayman) Limited (CUPR)

Market Cap	108.15M
Revenue (ttm)	71,619
Net Income (ttm)	-1.01M
Shares Out	21.00M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,298
Open	4.900
Previous Close	4.850
Day's Range	4.880 - 5.160
52-Week Range	3.510 - 6.720
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CUPR

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using m...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Apr 10, 2025
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: CUPR
• Website: https://www.cuprina.com.sg

Financial Performance

In 2023, CUPR's revenue was 100,773, an increase of 78.05% compared to the previous year's 56,599. Losses were -1.12 million, 2.29% more than in 2022.

Financial numbers in SGD